XML 69 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitment and Contingencies - Additional Information (Details)
3 Months Ended 9 Months Ended 31 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
LeaseAgreement
Feb. 28, 2019
USD ($)
Dec. 31, 2021
USD ($)
Commitments And Contingencies [Line Items]        
Number of operating lease agreements | LeaseAgreement   2    
Restricted cash $ 719,000 $ 719,000   $ 189,000
ALS Association and ALS Finding a Cure | Maximum | Cost of Sales        
Commitments And Contingencies [Line Items]        
Royalty expense 100,000 100,000    
Royalty Payments Agreements with Grantors        
Commitments And Contingencies [Line Items]        
Proceeds from grants     $ 4,300,000  
Royalty Payments Agreements with Grantors | ALS Association and ALS Finding a Cure        
Commitments And Contingencies [Line Items]        
Percentage of grant received     150.00%  
Percentage of net sales of products developed under projects     3.00%  
Percentage of cash proceeds from revenue generating transaction     3.00%  
Royalty Payments Agreements with Grantors | Alzheimer's Drug Discovery Foundation, the Alzheimer's Association, and Cure Alzheimer's Fund        
Commitments And Contingencies [Line Items]        
Maximum Royalty amount payable to each grantor     $ 15,000,000.0  
Aggregate royalty amount payable to grantor     $ 45,000,000.0  
Percentage of annual net sales of products commercialized from project     4.00%  
Percentage of all royalties and cash proceeds from revenue generating transaction     15.00%  
Collateral for Letter of Credit Issued        
Commitments And Contingencies [Line Items]        
Restricted cash 200,000 200,000    
Collateral for Corporate Credit Card Program        
Commitments And Contingencies [Line Items]        
Restricted cash $ 500,000 $ 500,000